![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercebiotech.com/biotech/barinthus-lays-25-sidelines-prostate-cancer-program-stretch-out-cash
https://www.globenewswire.com/news-release/2024/06/12/2897874/0/en/Barinthus-Bio-Announces-Strategic-Pipeline-Prioritization-Following-Positive-Interim-Data-from-VTP-300-in-Chronic-Hepatitis-B-Virus-Infections.html
https://www.globenewswire.com/news-release/2024/06/06/2894848/0/en/Barinthus-Bio-s-VTP-300-Trials-Demonstrate-Ability-to-Achieve-Undetectable-HBsAg-levels-and-Statistical-Significance-in-Lowering-HBsAg-Levels-in-People-with-Chronic-Hepatitis-B.html
https://www.globenewswire.com/news-release/2024/05/22/2886432/0/en/Barinthus-Bio-to-Present-VTP-300-Clinical-Data-Updates-at-EASL-Congress-2024.html
https://www.globenewswire.com/news-release/2024/05/13/2880370/0/en/Barinthus-Bio-Reports-First-Quarter-2024-Financial-Results-and-Update-on-Corporate-Developments.html
https://www.globenewswire.com/news-release/2024/05/01/2873089/0/en/Barinthus-Bio-Names-Experienced-Physician-Leon-Hooftman-M-D-as-Chief-Medical-Officer.html
https://investors.barinthusbio.com/news-releases/news-release-details/barinthus-bio-announces-topline-data-phase-1b2-apollo-trial-vtp
https://www.globenewswire.com/news-release/2024/04/18/2865826/0/en/Barinthus-Bio-Announces-Topline-Data-from-Phase-1b-2-APOLLO-Trial-of-VTP-200-in-Persistent-High-Risk-Human-Papillomavirus-HPV-Infections.html
https://www.globenewswire.com/news-release/2024/03/20/2849345/0/en/Barinthus-Bio-Reports-Full-Year-2023-Financial-Results-and-Update-on-Corporate-Developments.html
https://www.globenewswire.com//news-release/2024/01/05/2804866/0/en/Barinthus-Bio-Provides-a-Financial-Update-and-Announces-Anticipated-2024-Corporate-Milestones.html